Search Results - "NIGHTINGALE, Charles H"

Refine Results
  1. 1

    Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients by Li, Chonghua, Kuti, Joseph L., Nightingale, Charles H., Nicolau, David P.

    Published in Journal of clinical pharmacology (01-10-2006)
    “…The objectives of this study were to develop a meropenem population pharmacokinetic model using patient data and use it to explore alternative dosage regimens…”
    Get full text
    Journal Article
  2. 2

    Impact of Extended‐Spectrum β‐Lactamase–Producing Escherichia coli and Klebsiella Species on Clinical Outcomes and Hospital Costs: A Matched Cohort Study by Lee, Su Young, Kotapati, Srividya, Kuti, Joseph L., Nightingale, Charles H., Nicolau, David P.

    “…To evaluate the economic and clinical impact of infection with extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli and Klebsiella species…”
    Get full text
    Journal Article
  3. 3

    Optimizing Pharmacodynamic Target Attainment Using the MYSTIC Antibiogram: Data Collected in North America in 2002 by KUTI, Joseph L, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-07-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem by Kuti, Joseph L., Dandekar, Prachi K., Nightingale, Charles H., Nicolau, David P.

    Published in Journal of clinical pharmacology (01-10-2003)
    “…Prolonging the infusion of meropenem over 3 hours increases the percentage of the dosing interval that drug concentrations remain above the minimum inhibitory…”
    Get full text
    Journal Article
  5. 5

    Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic by McNabb, JoCarol, Ross, Jack W., Abriola, Kenneth, Turley, Christina, Nightingale, Charles H., Nicolau, David P.

    Published in Clinical infectious diseases (01-09-2001)
    “…This study's hypothesis is that human immunodeficiency virus—infected patients in the inner city (predominantly injection drug users and ethnic minorities) do…”
    Get full text
    Journal Article
  6. 6

    Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects by SUN, Heather K, DUCHIN, Kenneth, NIGHTINGALE, Charles H, SHAW, Jeng-Pyng, SEROOGY, Julie, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-02-2006)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations by SUN, Heather K, ONG, Christine T, UMER, Ambreen, HARYER, Dawn, TROY, Steven, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-04-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection by LACY, M. K, WEN LU, XIAOWEI XU, TESSIER, P. R, NICOLAU, D. P, QUINTILIANI, R, NIGHTINGALE, C. H

    Published in Antimicrobial Agents and Chemotherapy (01-03-1999)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula by MAGLIO, Dana, ONG, Christine, BANEVICIUS, Mary Anne, GENG, Qiuming, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-06-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    Cost Effect of Managing Methicillin-Resistant Staphylococcus Aureus in a Long-Term Care Facility by Capitano, Blair, Leshem, O. Alice, Nightingale, Charles H., Nicolau, David P.

    “…OBJECTIVES: The purpose of this study was to measure the total consumption of resources involved in the care of a long‐term care facility (LTCF) resident…”
    Get full text
    Journal Article
  11. 11

    Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs) by Ong, Christine T., Babalola, Chinedum P., Nightingale, Charles H., Nicolau, David P.

    Published in Journal of antimicrobial chemotherapy (01-09-2005)
    “…Objectives: To evaluate the penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs). Methods: PMNs were…”
    Get full text
    Journal Article
  12. 12

    The Pharmacodynamics of Aminoglycosides by Lacy, Melinda K., Nicolau, David P., Nightingale, Charles H., Quintiliani, Richard

    Published in Clinical infectious diseases (01-07-1998)
    “…Recently, a more complete understanding of the pharmacodynamics of aminoglycosides has been recognized, indicating that this class of antibiotics exhibits both…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients by Du, Xiaoli, Li, Chonghua, Kuti, Joseph L., Nightingale, Charles H., Nicolau, David P.

    Published in Journal of clinical pharmacology (01-01-2006)
    “…Meropenem is a highly potent carbapenem antibiotic against gram‐positive and gram‐negative bacteria. Meropenem plasma concentration data from 99 pediatric…”
    Get full text
    Journal Article
  14. 14

    Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia by TESSIER, Pamela R, KIM, Myo-Kyoung, WEN ZHOU, DAWEI XUAN, CHONGHUA LI, MIN YE, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-05-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  15. 15

    Pharmacodynamics of Moxifloxacin and Levofloxacin at Simulated Epithelial Lining Fluid Drug Concentrations against Streptococcus pneumoniae by FLOREA, Naomi R, TESSIER, Pamela R, CUILIAN ZHANG, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-04-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Pharmacodynamic Profile of Ertapenem against Klebsiella pneumoniae and Escherichia coli in a Murine Thigh Model by MAGLIO, Dana, BANEVICIUS, Mary Anne, SUTHERLAND, Christina, BABALOLA, Chinedum, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-01-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Comparison of Pharmacodynamic Target Attainment Between Healthy Subjects and Patients for Ceftazidime and Meropenem by Kuti, Joseph L., Horowitz, Sheryl, Nightingale, Charles H., Nicolau, David P.

    Published in Pharmacotherapy (01-07-2005)
    “…Study Objective. To compare the pharmacodynamics of two β‐lactams—ceftazidime and meropenem—in healthy subjects versus patients. Design. Monte Carlo simulation…”
    Get full text
    Journal Article
  19. 19

    Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model by TESSIER, Pamela R, MATTOES, Holly M, DANDEKAR, Prachi K, NIGHTINGALE, Charles H, NICOLAU, David P

    Published in Antimicrobial Agents and Chemotherapy (01-01-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20

    Pharmacodynamics of Meropenem and Imipenem Against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa by Kuti, Joseph L., Florea, Naomi R., Nightingale, Charles H., Nicolau, David P.

    Published in Pharmacotherapy (01-01-2004)
    “…Study Objective. To compare the pharmacodynamics of meropenem and imipenem, both administered as 500 mg every 6 hours, against populations of…”
    Get full text
    Journal Article